Actively Recruiting
Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)
Led by Mayo Clinic · Updated on 2026-04-15
2000
Participants Needed
1
Research Sites
1022 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the research is to identify mutations (defects in the genetic blueprint) that cause spontaneous coronary artery dissection (SCAD), in other words, spontaneous tears in blood vessels that supply the heart. Some mutations may be inherited (passed on) from a parent without an apparent blood vessel problem while others may develop for the first time in the affected person.
CONDITIONS
Official Title
Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men and women able to give informed consent and complete a 2 page questionnaire
- Diagnosis of one or more episodes of spontaneous coronary artery dissection (SCAD)
- Biological parent of individual with SCAD
- Relative with fibromuscular dysplasia, arterial aneurysm, or arterial dissection
You will not qualify if you...
- Lack of confirmation of SCAD diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
J
Jake Nemgar
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here